EV
Evelo Biosciences, Inc.
EVLO · OTC
$0.00 +0.00% (+$0.00)
1M -99.00%
Market Cap $1.90K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROIC 201.37%
ROA 177.72%
Debt
71 /100
Low Net debt/EBITDA -0.03x
Current ratio 4.16x
Int. coverage -23.31x
Stability
54 /100
Moderate Profitable years 0
Beta 1.31x
EPS volatility 21.29%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na EVLO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Craig R. Jalbert
Employees
66
Headquarters
Cambridge
Nadcházející události
17 LIS
Earnings
Upcoming earnings report